Dr. Paul Burridge is an Assistant Professor in Pharmacology at Northwestern University’s Feinberg School of Medicine. His lab uses hiPSCs and other next-generation tools to study the pharmacogenomic and molecular mechanisms of chemotherapy-induced cardiomyopathy.

His recent review article highlights the importance of hiPSC technology for drug discovery, and in advancing precision medicine in cardio-oncology.